← Leaderboards
Marc A. Shuman
University Of California San Francisco
$13,809,068
Attributed
$13,809,068
Total exposure
6
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.9M · FY2005–13$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
Funding mix
By agency
NIH$16,840,121 · 7
By mechanism
P50$12,257,608 · 3
P01$3,241,598 · 2
T32$1,340,915 · 1
P30$0 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of California San Francisco
Same institution · by research overlap
- Michael A. Matthay$26,142,041
- Gail T Colbern$1,034,095
- Roderic H Phibbs$25,799
- Andrew Leavitt$1,336,327
- Dean Sheppard$47,450,983
Others in their field
Top investigators on “Neoplasm /Cancer Genetics”
- Gregory H Reaman · National Childhood Cancer Foundation$112,559,481
- Charles A Coltman · Southwest Oncology Group$46,831,444
- Samuel A Wells · Duke University$32,148,803
- David Sidransky · Johns Hopkins University$27,906,864
- Brian E Henderson · University Of Southern California$27,493,155
- Bruce W Stillman · Cold Spring Harbor Laboratory$22,532,365
Research focus
Neoplasm /Cancer GeneticsAngiogenesisProstate NeoplasmsNeoplastic ProcessMetastasisNeoplastic GrowthGenetically Modified AnimalsHuman TissueLaboratory MouseProtease InhibitorBasic ScienceHematologyOncologyNuclear Magnetic Resonance SpectroscopyNeoplasm /Cancer ChemotherapyPlasminogen Activator InhibitorsPrognosisBreast NeoplasmsExtracellular MatrixModel Design /DevelopmentGene ExpressionPlasminMonoclonal AntibodyDisease /Disorder Model
Grant awards (29)
Basic Research in Hematology and Oncology$190,138
T32 · FY2013 · DK · contact PI
Basic Research in Hematology and Oncology$186,693
T32 · FY2012 · DK · contact PI
Basic Research in Hematology and Oncology$108,560
T32 · FY2011 · DK · contact PI
Basic Research in Hematology and Oncology$189,607
T32 · FY2010 · DK · contact PI
Basic Research in Hematology and Oncology$189,607
T32 · FY2009 · DK · contact PI
Basic Research in Hematology and Oncology$244,251
T32 · FY2008 · DK · contact PI
Basic Research in Hematology and Oncology$232,059
T32 · FY2007 · DK · contact PI
UCSF PROSTATE CANCER SPORE$1,878,533
P50 · FY2005 · CA
UCSF PROSTATE CANCER SPORE$60,000
P50 · FY2005 · CA
UCSF PROSTATE CANCER SPORE$2,265,599
P50 · FY2003 · CA
PROTEASES IN CANCER--BIOLOGY AND DRUG DEVELOPMENT$59,571
P01 · FY2003 · CA
UCSF PROSTATE CANCER SPORE$2,195,771
P50 · FY2002 · CA
PROTEASES IN CANCER--BIOLOGY AND DRUG DEVELOPMENT$347,904
P01 · FY2002 · CA
THERAPEUTIC BLOCKADE OF THE UROKINASE RECEPTOR$206,819
P50 · FY2002 · CA
THERAPEUTIC BLOCKADE OF THE UROKINASE RECEPTOR$206,819
P50 · FY2002 · CA
PROTEASES--TUMOR BIOLOGY$0
P01 · FY2002 · CA
UCSF PROSTATE CANCER SPORE$2,320,920
P50 · FY2001 · CA
PROTEASES IN CANCER--BIOLOGY AND DRUG DEVELOPMENT$1,328,283
P01 · FY2001 · CA
THERAPEUTIC BLOCKADE OF THE UROKINASE RECEPTOR$206,819
P50 · FY2001 · CA
THERAPEUTIC BLOCKADE OF THE UROKINASE RECEPTOR$206,819
P50 · FY2001 · CA
Genitourinary oncology program$0
P30 · FY2001 · CA
Genitourinary oncology program$0
P30 · FY2001 · CA
PROTEASES--TUMOR BIOLOGY$0
P01 · FY2001 · CA
UCSF PROSTATE CANCER SPORE$2,341,539
P50 · FY2000 · CA
PROTEASES IN CANCER--BIOLOGY AND DRUG DEVELOPMENT$1,295,295
P01 · FY2000 · CA
PROTEASES--TUMOR BIOLOGY$210,545
P01 · FY2000 · CA
THERAPEUTIC BLOCKADE OF THE UROKINASE RECEPTOR$206,819
P50 · FY2000 · CA
C-MPL LIGAND IN HEALTH AND DISEASE$161,151
P50 · FY2000 · HL
Genitourinary oncology program$0
P30 · FY2000 · CA